MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹825 Cr | ₹682 Cr | ₹436 Cr | ₹354 Cr | ₹280 Cr |
What is the latest Short Term Provisions ratio of MANKIND PHARMA ?
| Year | Short Term Provisions |
|---|---|
| Mar2026 | ₹825 Cr |
| Mar2025 | ₹682 Cr |
| Mar2024 | ₹436 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹280 Cr |
How is Short Term Provisions of MANKIND PHARMA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹825 Cr | 20.93 | |
| Mar2025 | ₹682 Cr | 56.52 | |
| Mar2024 | ₹436 Cr | 23.12 | |
| Mar2023 | ₹354 Cr | 26.57 | |
| Mar2022 | ₹280 Cr | - | |
Compare Short Term Provisions of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹100,138.0 Cr | -0.3% | -4.2% | -7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.3% |
-4.2% |
-7.3% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses